Skip to content 
The entire preceding procedure has gone perfectly. The embryos have developed well in the laboratory, the surrogates is ready, the tests are accurate, and the medical team confirms that the endometrium has a perfect appearance. However, the most crucial and delicate moment of the entire process remains: the embryo transfer in surrogacy. It is a medical procedure that takes only a few minutes, but encompasses months of clinical preparation, coordination, and hope. What happens in that brief moment can signal the beginning of a successful pregnancy or the need to reconsider the entire process.
Understanding how embryo transfer works, what medical protocols are applied, and what factors influence implantation is fundamental for anyone learning about surrogacy in the early stages of their process. It’s not just another assisted reproductive technology; it’s the intersection of biology, reproductive medicine, and individualized clinical planning.
Embryo transfer in surrogacy is the process by which one or more embryos, previously created through in vitro fertilization, are implanted into the surrogate’s uterus. This is done so that the pregnancy begins and the embryos implant. While technically similar to transfer in other assisted reproductive technologies, in this case it has unique characteristics that arise from the collaboration between the intended parents, the embryology laboratory, and the medical team that supervises the surrogate.
Before reaching that point, the process begins much earlier. After ovarian stimulation and egg retrieval, fertilization takes place in the laboratory. The embryos are cultured for several days, generally until the blastocyst stage, allowing for better embryo selection based on morphological and, in some cases, genetic criteria. This extended culture period is part of current medical protocols aimed at optimizing implantation rates and reducing risks associated with unnecessary transfers.
Simultaneously, the surrogate begins a carefully monitored endometrial preparation process. This is where medical protocols play a crucial role. The goal is to coordinate embryo development with the ideal period of endometrial receptivity. Various therapeutic methods are used, but hormonal treatments, including progesterone and estrogen, are frequently employed to artificially simulate the stages of the menstrual cycle and ensure the endometrium has the appropriate structure and thickness.
The endometrium must not only have sufficient thickness, usually assessed by transvaginal ultrasound, but also a characteristic trilaminar morphology and a receptive biochemical environment. Implantation is a complex phenomenon that depends on the molecular interaction between the embryo and the endometrial tissue. Therefore, medical protocols are not limited to administering hormones, but also include laboratory tests, ultrasound monitoring, and individualized adjustments based on each surrogate’s response.
In the context of surrogacy, this preparation is particularly important since the uterus that will receive the embryo has not been involved in gamete retrieval or ovarian stimulation. This requires precise coordination so that the embryo transfer interval coincides with the limited implantation window, which is when the endometrium is biologically ready to allow the embryo to attach.
When the embryo transfer is finally scheduled for surrogacy, the procedure is performed in a controlled clinical setting. It generally does not require anesthesia, as it is painless and minimally invasive. Under abdominal ultrasound guidance, the specialist inserts a thin catheter through the cervix and carefully places the embryo into the uterine cavity. Precision in this procedure is crucial. The exact position within the uterus, the gentleness of the manipulation, and the absence of excessive uterine contractions are all factors that can influence the outcome.
Although it may seem like a simple procedure from the outside, embryo transfer involves complex logistics in the laboratory. If the selected embryo comes from a previous cryopreservation cycle , it is thawed and evaluated before being placed in the catheter. The embryologist checks its viability and quality just before the procedure. This collaboration between the clinic and the laboratory is part of the medical protocols established to reduce risks and increase the chances of success.
One of the aspects that most interests those researching surrogacy is what actually determines implantation. The answer is neither singular nor simple. Embryonic, endometrial, and even immunological factors are involved. Embryo quality is one of the most decisive elements. An embryo with adequate development, good morphology, and, where applicable, normal results in preimplantation genetic testing has a greater probability of implanting.
However, pregnancy is not guaranteed simply because the embryo is of excellent quality. The condition of the endometrium is also essential. Medical protocols here aim to improve the uterine environment through precise hormonal preparation. An excessively thin endometrium can be associated with lower implantation rates. On the other hand, structural changes, such as submucosal fibroids, synechiae, or polyps, can mechanically hinder embryonic attachment. For this reason, thorough investigations are conducted to rule out any uterine conditions before the cycle begins.
There are also less visible factors, such as the molecular receptivity of the endometrium. Implantation involves a biochemical dialogue between the embryo and the uterus, mediated by cytokines, adhesion molecules, and growth factors. Although not all of these parameters are always analyzed in standard clinical practice, research in assisted reproduction has led to a better understanding of why some cycles do not result in pregnancy despite a technically correct transfer.
Furthermore, in surrogacy, particular attention is paid to ensuring the surrogate maintains a stable emotional and physical state after embryo transfer. While there is no conclusive evidence that complete bed rest improves implantation rates, maintaining a balanced lifestyle and avoiding strenuous activity are recommended. Medical and psychological support is an essential part of current medical protocols, given that overall well-being can have an indirect impact on the process.
After the embryo transfer, what is popularly known as the “beta wait” begins, the interval of approximately ten to fourteen days until the determination of the beta- hCG hormone. in the blood. This period generates a great emotional charge. From a physiological point of view, during these days the embryo must hatch, attach to the endometrium, invade it, and begin to produce detectable hormonal signals. If implantation occurs correctly, beta- hCG levels will gradually increase, confirming the start of pregnancy.
It is important to understand that, even when rigorously following all medical protocols, not all transfers result in a successful pregnancy. Reproductive medicine works with probabilities, not absolute certainties. Each attempt provides valuable information for adjusting future strategies, whether by modifying endometrial preparation, reviewing embryo quality, or reconsidering the number of embryos transferred, always within the guidelines of safety and clinical ethics.
In our blog section, we have several articles in which we analyze each of these topics, from “Success rates and medical considerations in surrogacy with frozen embryos” until “Egg vitrification improves reproductive possibilities in surrogacy processes”.
Another important aspect is the decision between fresh or delayed embryo transfer after cryopreservation. Currently, many centers opt for delayed transfer, allowing the endometrium to be prepared in a separate cycle. This strategy can improve synchronization and reduce the hormonal impact of ovarian stimulation. In the context of surrogacy, this separate planning facilitates greater personalization of medical protocols and safer logistical organization.
Blastocyst transfer in most cases, with the aim of minimizing the risk of multiple pregnancies, which can increase obstetric complications. This decision is part of a medical strategy focused on prioritizing the safety of both the surrogate and the future baby.
When embryo transfer in surrogacy results in pregnancy, subsequent monitoring is carried out using serial ultrasounds to confirm proper intrauterine implantation, the presence of a gestational sac, and later, embryonic cardiac activity. From that point on, obstetric care continues according to standard procedures, maintaining close coordination between the medical team and all parties involved.
For those in the early stages of learning, it’s crucial to understand that success doesn’t depend on a single, isolated factor. Every step is designed to create the most favorable conditions possible.
